Dr. Nassim Akle, M.D.
What this data tells you about Dr. Akle
Dr. Nassim Akle is a radiology - diagnostic neuroimaging in Houston, TX, with 16 years in practice. Based on federal Medicare data, Dr. Akle performed 13,435 Medicare services across 2,003 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akle received a total of $10,391 from 20 pharmaceutical and/or device companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic neuroimaging. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| MRI contrast dye injection (gadoterate) | 9,954 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 1,260 | $0 | $2 |
| Bone density scan (DEXA) | 243 | $36 | $111 |
| Chest X-ray, 1 view | 193 | $7 | $59 |
| Injection, gadoteridol, (prohance multipack), per ml | 193 | $1 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 132 | $10 | $84 |
| Complete ultrasound scan behind abdominal cavity | 104 | $28 | $252 |
| Drainage of fluid from abdominal cavity using imaging guidance | 103 | $86 | $702 |
| Mri scan of brain without contrast | 96 | $123 | $571 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 72 | $132 | $548 |
| Mri scan of brain before and after contrast | 71 | $242 | $972 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 65 | $15 | $177 |
| Ultrasonic guidance for blood vessel access | 63 | $12 | $173 |
| Limited ultrasound scan of abdomen | 60 | $23 | $202 |
| Complete ultrasound scan of abdomen | 47 | $79 | $344 |
| Ultrasonic guidance for needle placement | 44 | $25 | $233 |
| Ct scan of blood vessels of chest with contrast | 39 | $71 | $596 |
| Mri scan of upper spinal canal without contrast | 37 | $71 | $548 |
| Mri scan of blood vessels of head without contrast | 35 | $45 | $405 |
| Ct scan of blood vessels of head with contrast | 34 | $68 | $593 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 32 | $73 | $347 |
| Aspiration of fluid from chest cavity using imaging guidance | 30 | $88 | $1,075 |
| Ct scan of blood vessels of neck with contrast | 29 | $66 | $592 |
| Chest X-ray, 2 views | 29 | $8 | $72 |
| Mri scan of lower spinal canal without contrast | 29 | $75 | $518 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 25 | $211 | $1,869 |
| Ct scan of upper spine without contrast | 23 | $38 | $393 |
| Review by radiologist of ct guidance for needle placement | 23 | $57 | $392 |
| Ultrasound of leg arteries or artery grafts | 21 | $150 | $655 |
| Insertion of central venous tube with port (5 years or older) | 19 | $272 | $2,256 |
| Nuclear medicine study of brain with metabolic evaluation | 19 | $1,174 | $4,450 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | $92 | $660 |
| Removal of tunneled central venous tube | 18 | $107 | $942 |
| Needle biopsy of kidney | 18 | $103 | $1,050 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | $69 | $791 |
| Mri scan of blood vessels of neck without contrast | 17 | $45 | $403 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 17 | $85 | $804 |
| Ultrasound scan of organ tissue for measuring elasticity | 17 | $24 | $198 |
| X-ray of lower and sacral spine, 2-3 views | 16 | $8 | $80 |
| Mri scan of middle spinal canal without contrast | 16 | $55 | $542 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $70 | $341 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $61 | $619 |
| Interpretation of trabecular bone score (tbs) and report on fracture risk | 15 | $8 | $85 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $10 | $107 |
| Ct scan of face without contrast | 13 | $99 | $389 |
| Ultrasound of both sides of head and neck blood flow | 13 | $110 | $504 |
| Removal of spinal fluid with lower back spinal tap for diagnostic test using imaging guidance | 12 | $71 | $538 |
| CT scan of head/brain, without contrast | 12 | $72 | $320 |
| X-ray of middle spine, 3 views | 12 | $9 | $77 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $31 | $378 |
| Ct scan of lower spine without contrast | 11 | $37 | $391 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 11 | $45 | $573 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for radiology - diagnostic neuroimaging in TX.
Geographic Context
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Akle is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), and high industry engagement (consulting-driven, top 0%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Akle experienced with mri contrast dye injection (gadoterate)?
Does Dr. Akle receive payments from pharmaceutical companies?
How do Dr. Akle's costs compare to other radiology - diagnostic neuroimagings in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology